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Background: Maternal diabetes is known to impair placental function; however, its effect on 
placental expression of progesterone/oestrogen receptors and role of the placenta in foetal 
programming has not been well documented. The study assessed serum progesterone and 
oestradiol levels, placental morphology, placental progesterone and oestrogen receptors 
expression in insulin resistant rats. Methods: Virgin female rats were randomly divided into 2 
groups; control group fed normal rat chow and insulin resistant group fed a diet containing 25% 
fructose w/w orally for 12 weeks. Rats in both groups were mated with proven male rats and 
presence of sperm cells in vaginal smear the following morning was taken as day 1 of pregnancy. 
Maternal blood and amniotic fluid samples were obtained and assessed for glucose, insulin, C-
peptide, progesterone and oestradiol levels. Quantitative insulin sensitivity check index 
(QUICKI) was estimated from fasting blood glucose and insulin values. Placental tissues were 
isolated, weighed and fixed for morphological studies and the expression of oestrogen and 
progesterone receptors using immunohistochemical technique. Results: Maternal blood and 
amniotic fluid glucose, insulin, C-peptide levels, placental weight and diameter were 
significantly increased; while QUICKI was significantly lower (P < 0.05) in the insulin resistant 
rats compared to control rats. Placental junctional zones were enlarged due to an increase in the 
number of glycogen and trophoblast giant cells in the insulin resistant rats. Progesterone receptor 
expression was down regulated, with no significant difference in oestrogen receptor expression 
in the insulin resistant rat placentae. Conclusion: The results suggest that maternal insulin 
resistance impairs progesterone production, placental morphology and down regulates placental 
progesterone receptor expression in this animal model of type 2 diabetes mellitus. 
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INTRODUCTION   
Diabetes is a common metabolic disorder of pregnancy 
with a global prevalence ranging from 2% to 14% 
depending on the population studied. Gestational 
diabetes mellitus (GDM) and type 2 diabetes mellitus 
(T2D), constitute over 90% of diabetic pregnant cases 
(Al-Noaemi and Shalayel, 2011; Vambergue and 
Fajardy, 2011). Foetal exposure to a compromised intra-
uterine environment impairs foetal growth and 
metabolic processes with long term consequences for the 
offspring’s    health,  a   phenomenon termed    foetal  
programming (Barker, 1998; Armitage et al., 2005). 
However, the mechanisms through which the offspring 
of diabetic mothers are programmed for metabolic 
disorders in later life, have not been fully documented. 
Pregnancy induces metabolic changes in maternal 
circulation, due to pregnancy hormones, which is 
essential to meet energy demands of the foetus. These 
changes increase resistance to insulin, as most 
pregnancy hormones are insulin antagonist, thus 
enhancing glucose availability and supply to the 
developing foetus (Barbour et al., 2007). Pancreatic beta 
cells however compensate for the increased demand for 
insulin, and a normoglycemic state is maintained. 
However, women who develop GDM exhibit a defect in 
insulin secretion, increased hepatic glucose production 
and resistance to insulin action, all of which contribute 
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to the development of overt hyperglycaemia (Kuhl, 
1991).  
Although the precise mechanisms by which 
pregnancy hormones interact with pancreatic beta cells 
to produce glucose intolerance during pregnancy are 
uncertain, it has been suggested that the final common 
pathway responsible for the development of GDM is an 
incomplete compensation of pancreatic beta cells to 
increase insulin secretion in proportion to elevated 
circulating glucose levels. This results in the 
manifestation of hyperglycaemia, hyperinsulinemia, 
impaired glucose tolerance and gestational diabetes 
mellitus (Kahn, 1998).  
In recent years, scientists have recognized that 
genetic factors are unable to fully explain the 
development of GDM. Increased dietary intake of food, 
drinks and beverages high in sugars, have been 
suggested to directly promote glucose intolerance during 
pregnancy. Consumption of such diets adversely affects 
energy metabolism causing hyperglycaemia and insulin 
resistance (Al-Noaemi and Shalayel, 2011). Fructose is 
an isomer of glucose and its free form is produced 
commercially through the isomerization of glucose. 
Fructose is commonly used as sweetener in processed 
foods, drinks and beverages.  
High influx of fructose to the liver, the main organ 
for its metabolism, perturbs glucose uptake. This occur 
due to increased glycerol and acyl portions of 
triglyceride molecules from fructose metabolism 
(Basciano et al., 2005). Fructose by–passes the rate 
limiting step of glucose metabolism, providing an 
unregulated amount of lipogenic substrates for 
conversion to fatty acids and triglyceride, as well as 
upregulating transcription factors and enzymes involved 
in lipogenesis. Increased stimulation of insulin 
production occurs after fructose consumption, resulting 
in a decreased activation of adipose tissue lipoprotein 
lipase (Sloboda et al., 2014). Fructose therefore acts by 
impairing glucose disposal leading to a compensatory 
hyperinsulinaemia. A reversible hyperglycaemia and 
hyperinsulinemia (type 2 diabetes mellitus) can 
therefore be induced by chronic fructose feeding in 
animal models (Suga et al., 2000; Basciano et al., 2005; 
Arikawe et al., 2008; Iranloye et al., 2011). 
The placenta function to provide endocrine 
secretions and selective exchange of substances through 
its apposition to both uterine and trophoblastic 
vasculature. Owing to its position, the functions of the 
placenta can be impaired by adverse maternal conditions 
such as diabetes mellitus (Jansson and Powell, 2007; 
Sferuzzi-Perri and Camm, 2016), which may occur via 
modulations in the expression of hormone receptors and 
substrate transporters on placental surfaces (Hiden and 
Desoye, 2010). Placental hormones are secreted mainly 
by the syncytiotrophoblast in a highly regulated manner. 
The hormones are important for the maintenance of 
pregnancy, exerting autocrine and paracrine effects that 
regulate decidualization, placental development, 
angiogenesis, endometrial receptivity, embryo 
implantation, immune-tolerance and foetal development 
(Costa, 2015). 
Progesterone is a steroid hormone crucial for the 
maintenance of pregnancy; hence it is also called the 
‘hormone of pregnancy’. The corpus luteum is the main 
source of progesterone during the first weeks of 
pregnancy, owing to human chorionic gonadotropin 
(hCG) stimulation. As hCG concentration declines, the 
placenta gradually becomes the main source of 
progesterone production (Tuckey, 2005). This hormone 
is mainly synthesized from maternal cholesterol, 
through a two-step reaction occurring in the 
syncytiotrophoblast mitochondria.  
Maternal blood levels of progesterone increase 
throughout pregnancy, peaking during the last 4 weeks 
of gestation and decreasing after labour and placental 
delivery. Progesterone exerts genomic and non-genomic 
actions, by activating its receptors. The classic nuclear 
progesterone receptors (PR), PRα and PRβ, are 
ubiquitously expressed in the female reproductive tract 
and the placenta, they dimerize after progesterone 
binding, mediating its genomic action by binding to 
specific DNA elements in the promotor of target genes. 
In addition, PR may also mediate cytoplasmic signalling 
pathways (Carlos et al., 2013).  
 In addition to placentation, progesterone prepares 
the mammary gland for lactation by enhancing the 
proliferation of mammary epithelium, but prevents 
lactation until labour, antagonizing the prolactin effect 
(Pang and Hartmann, 2007).  Progesterone has been 
reported to be involved in metabolic changes during 
pregnancy, promoting hyperphagia, fat storage and 
insulin resistance E2 (Butte, 2000). The effect of 
progesterone, mediated by its receptors identified in the 
placenta aside the uterus, suggests that the placenta itself 
is a target tissue for progesterone action (Tsai and 
O'Malley, 1994; Shanker and Rao, 1999).  
Oestrogens are produced primarily by the ovaries in 
the non-pregnant state and by the placenta, during 
pregnancy. Placental oestrogens are a group of four 
different steroid hormones: oestrone (E1), 17β-
oestradiol (), estriol (E3) and oestetrol (E4). During the 
first weeks of gestation, the oestrogens are produced by 
the corpus luteum, after which the placenta takes over 
the synthesis of these steroids. Blood levels of all 
oestrogens increase throughout pregnancy, peaking at 
term. Oestradiol is the most abundant oestrogen and has 
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been reported to inhibit lipolysis, promote 
hyperlipidaemia (Butte, 2000) and the development of 
physiological insulin resistance of pregnancy (Gonzalez 
et al., 2000; Gonzalez et al., 2002; Barros et al., 2009). 
The actions of oestrogens are mediated by oestrogen 
receptors (ER), which are proteins activated when bond 
to oestrogens. Little is however known about the effect 
of maternal insulin resistance on placental expression of 
oestrogen and progesterone receptors.  
 
MATERIALS AND METHODS 
Animals  
Sixteen female Sprague-Dawley rats aged 6 weeks, 
weighing 110 - 120 g were obtained from the Laboratory 
Animal Department, and ethical approval obtained from 
the College of Medicine, University of Lagos, Lagos. 
Guidelines with the use and care of laboratory animals 
were strictly adhered to. The animals were housed in 
clear polypropylene cages lined with wood chip 
beddings. Animals were kept under standard conditions 
of temperature 27ºC - 30ºC, with 12h light/dark cycle 
and were randomly divided into 2 groups. Group 1 
served as the control group and was fed with standard rat 
chow. Group 2 served as the insulin resistant (IR) group 
and was fed ad libitum on a special diet containing 25% 
fructose (SIGMA Aldrich, USA) mixed with 75% 
normal rat chow weight/weight for 12 weeks (Arikawe 
et al., 2013). At this fructose concentration, insulin 
resistance state was 100% achieved with zero mortality 
rate.  
Body weight and fasting blood glucose levels were 
measured at the beginning of the experiment and weekly 
from the tail vein of the rats in both groups using 
Dextrostix Test Strips (Bayer Corporation, U. K.) after 
an overnight fast till diabetes was induced in the IR rats. 
Hyperglycaemia was confirmed using the glucose 
oxidase method (Hugget and Nixon, 1957). All animals 
had free access to drinking water throughout the duration 
of the study. The procedures were performed in 
accordance with guidelines of the College Ethical 
Committee on the use of laboratory animals for research. 
 
Vaginal smears and Induction of pregnancy  
The stages of estrous cycle in control and insulin 
resistant groups was determined by microscopic analysis 
of the predominant cell type in vaginal smears obtained 
daily from the 10th week till the 12th week of feeding i.e. 
a two-week period (Marcondes, et al., 2002). Only 
female rats showing two consecutive estrous cycles of 
the same length were used (Cruz, et al., 1990). 
Pregnancy was induced at the end of the 12th week of 
fructose feeding by mating at night a pro-estrous female 
rat with mature and proven adult male rat at ratio 2:1. 
This was to ensure that copulation occurred at estrus, the 
only time the female rat is receptive to the male rat. 
Successful mating was confirmed by the presence of 
sperm cells in the vaginal smear and was regarded as day 
1 of pregnancy.  
 
Sample collection and assay of parameters  
Cervical dislocation was carried out on rats in the two 
groups on day 19 of pregnancy. Maternal blood samples 
were collected by cardiac puncture into plain sample 
bottles, allowed to clot and centrifuged at 3,000 rpm for 15 
minutes to get clear serum samples, which were 
subsequently kept frozen (-20ºC) until measurement of the 
different parameters (insulin,      C-peptide, progesterone 
and oestradiol levels) using Enzyme-linked 
immunosorbent assay (ELISA) kits procured from 
Elabscience, FRC.  Laparatomy was done and the gravid 
uterus exposed, clear amniotic fluid was obtained from 
the gestational sacs using a 28G needle and 1ml syringe. 
 
Quantitative Insulin Sensitivity Check Index (QUICKI) 
QUICKI is an index for assessing insulin sensitivity as 
the reference glucose clamp (Cacho et al., 2008). This 
index was derived for maternal blood and amniotic fluid 
samples using fasting blood glucose and insulin levels, 
as the inverse log sum of glucose levels in milligram per 
decilitre and insulin levels in micro - unit per millilitre. 
Formula: QUICKI= 1 / [log (Io) + log (Go)], where Io = 
fasting insulin;  Go = fasting glucose (Katz et al., 2000). 
 
Assessment of placental parameters and morphological 
studies 
The gestational sacs were carefully opened following 
laparatomy and amniocentesis to isolate placental 
tissues. These were weighed, placental thickness and 
diameter were measured using a vernier caliper and the 
tissues fixed for morphological and immunohistological 
studies. Following placental tissue isolation for 
morphological studies, tissues were fixed in 10% formol 
saline, subsequently dehydrated in ascending grades of 
ethyl alcohol starting from 50% to two changes of 
absolute alcohol. Tissues were cleared in xylene, 
infiltrated with paraffin wax, embedded at 560C and 
sectioned at 3µm. The sections were obtained at five 
different non-adjacent levels through the placentae with 
the third level being at the approximate midpoint. 
Sections were mounted on glass slides and the method 
described by Fischer et al., (2008) was adopted for 
hematoxylin and eosin staining in the following 
sequence. 
 
Immunohistochemical detection of oestrogens and 
progesterone receptors (ER and PR) 
Paraffin embedded sections (3µm thick) were 
deparaffinized and rehydrated in a graded series of 
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alcohol. Following a rinse with phosphate buffered 
saline (PBS), the endogenous peroxide was blocked and 
the sections were incubated with 0.5 % bovine serum 
albumin for 30 minutes. The sections were afterwards 
incubated overnight with ER and PR antibodies 
respectively at 4oC, rinsed in PBS three times for five 
minutes each, followed by incubation with a biotinylated 
secondary antibody for 30 minutes at room temperature 
and for further 30 minutes with a streptavidin-peroxidase 
complex. Immunostaining was enhanced and visualized 
with 3, 3-diaminobenzidine (DAB) after sections were 
counterstained with Harris hematoxylin. 
 
Quantitative immunoreactivity and image analysis 
To quantify the expression of oestrogens and 
progesterone receptors (ER and PR) in the placental 
tissues, an Apex microscope was connected to a 
computer using an Apex Minigrab (Apex Microscopes, 
Wiltshire, UK). The number of golden stained nucleus 
per high-power field (HPF) in placenta sections from the 
control and insulin resistant rats were determined using 
an image processing program-Image J (National 
Institutes of Health, Bethesda, USA).  
 
Statistical analysis 
Analysis of data was done using GraphPad Prism 
version 6.00 for windows (GraphPad Software, San 
Diego, California). Results are expressed as mean ± 
standard error of mean (S.E.M). The significance of 
difference between groups were analysed using 
Student’s t-test. Differences were considered 
statistically significant at P < 0.05. 
 
RESULTS 
Effect of fructose feeding on FBG levels in non-pregnant 
female rats 
Fasting blood glucose (FBG) levels following fructose 
feeding are shown in Figure 1. FBG levels were not 
significantly different in the insulin resistant rats 
compared to control rats at the beginning of the 
experiment till the 4th week (insulin resistant group: 
initial- 79.8 ± 5.5 mg/dl, 1st week- 80.4 ± 3.4 mg/dl, 2nd 
week - 82.4 ± 6.0 mg/dl, 3rd week- 88.4± 4.1 mg/dl, 4th 
week- 89.6± 3.2 mg/dl); (control group: initial- 78.5 ± 
6.3 mg/dl, 1st week- 76.7± 4.3 mg/dl, 2nd week- 80.8 ± 
5.4 mg/dl, 3rd week- 82.2 ± 7.6 mg/dl, 4th week- 87.5± 
6.3 mg/dl) respectively. FBG levels were however 
significantly increased (P < 0.05) from the 8th to the 12th 
week in the insulin resistant rats (105.2 ± 8.4 mg/dl, 
120.6 ± 6.8 mg/dl, 124.9 ± 4.6 mg/dl and 130.1 ± 5.8 
mg/dl) compared to control rats (84.6 ± 6.5 mg/dl, 78.8 
± 3.2 mg/dl, 80.0 ± 6.4 mg/dl and 78.1± 5.2 mg/dl) 
respectively.  Insulin-resistant   rats fed on 25% fructose 
 
Fig. 1: Fasting blood glucose (FBG) levels of control and 
insulin resistant (IR) female rats following fructose feeding. 
FBG levels were significantly increased (*P < 0.05) in IR rats 
from the 8th week of feeding compared to control rats. 
 
 
Figure 2: Maternal serum and amniotic fluid glucose levels in 
control and insulin resistant (IR) pregnant rats. Glucose levels 
in maternal serum and amniotic fluid were increased (*P < 
0.05) in IR compared to control rats. 
 
 
w/w diet had FBG levels >120mg/dl (diabetic threshold) 
at the end of the 12th week of feeding. 
 
Effect of insulin resistance (IR) on maternal serum and 
amniotic fluid glucose levels in pregnant rats 
Fasting blood glucose (FBG) levels in control and IR 
pregnant rats are shown in Figure 2.  Maternal FBG 
levels in pregnant rats were significantly increased (p < 
0.05) in IR rats (146.9 ± 9.1 mg/dl) compared to control 
rats (97.2 ± 4.8 mg/dl). Likewise, amniotic fluid glucose 
levels were significantly increased (P < 0.05) in IR rats 
compared to control pregnant rats (Figure 2). 
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Fig. 3: Maternal serum and amniotic fluid insulin levels in 
control and insulin resistant (IR) pregnant rats. Insulin levels 
in maternal serum and amniotic fluid were increased (*P < 
0.05) in IR compared to control rats. 
 
 
Fig. 4: Maternal serum and amniotic fluid C-peptide levels in 
control and insulin resistant (IR) pregnant rats. C-peptide 
levels in maternal serum and amniotic fluid were increased 
(*P < 0.05) in IR compared to control rats. 
 
Effect of insulin resistance (IR) on maternal serum and 
amniotic fluid insulin levels in 
pregnant rats 
Maternal serum and amniotic fluid insulin levels in IR 
and control pregnant rats are shown in Figure 3. IR rats 
had significantly increased (P < 0.05) insulin levels (54.1 
± 2.1µIU/mL, 8.8 ± 0.2 µIU/mL) compared to control 
rats (27.2 ± 0.7 µIU/mL, 3.1 ± 0.2 µIU/mL) respectively. 
  
Fig. 5: QUICKI values of maternal serum and amniotic fluid 
in insulin resistant (IR) and control pregnant rats. A decrease 
(*P < 0.05) was observed in maternal serum and amniotic fluid 
QUICKI levels compared to Controls. 
 
 
Fig. 6: Maternal serum progesterone and oestradiol levels in 
insulin resistant (IR) and control pregnant rats. Progesterone 
levels were increased (*P < 0.05) in IR rats while no 
significant difference was observed in oestradiol levSNSels of 
IR compared to control rats. 
 
Effect of insulin resistance (IR) on maternal serum and 
amniotic fluid C-peptide levels in 
pregnant rats 
C-peptide levels in maternal serum and amniotic fluid of 
IR and control pregnant rats are shown in Figure 4. A 
significant increase (P < 0.05) was observed in the 
maternal serum and amniotic fluid C-peptide levels of 
IR pregnant rats (30.2+4.3ng/ml, 19.1+3.8ng/ml) 
compared to control rats (23.6+2.5ng/ml, 9.1+2.2ng/ml) 
respectively.  
 
Effect of insulin resistance (IR) on maternal serum and 
amniotic fluid QUICKI values in pregnant rats 
QUICKI of maternal serum and amniotic fluid of IR and 
control rats, derived from maternal and amniotic fluid 
insulin (Io) and glucose (Go) levels as the inverse log 
sum of insulin in micro - unit per millilitre and glucose in 
milligram per decilitre, are shown in Figure 5. QUICKI of 
pregnant IR rats were significantly (P < 0.05) lower 
(0.116+0.002, 0.057+0.002) compared to control rats 
(0.223+0.001, 0.090+0.002) respectively. 
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Fig. 7: Picture of Day 19 foetuses and placentae of insulin resistant (IR) and control rats. (Sony cybershot 12.1 MP Digital 
Camera X46). The placental diameter of IR rats was seen to be larger compared to control rats. 
   
 
Fig. 8: (a) Photomicrographs of day 19 control rat placenta and 
(b) IR rat placenta showing the compartments namely decidua 
(D), junctional zone (JZ) and labyrinth zone (LZ). The JZ is seen 
as enlarged in IR placentae. H&E stain (40x) Scale bars-100μm. 
(c) control and (d) insulin resistant rat placenta showing the 
junctional zone (JZ) composed of trophoblast giant cells (TGC), 
spongiotrophoblast cells (ST) and glycogen-containing cells 
(GC) PAS stain. 100x. Scale bars- 25μm. GC is increased in the 
IR compared to control placentae.  
 
Effect of insulin resistance (IR) on serum progesterone 
and oestradiol levels in pregnant rats 
Serum progesterone levels were significantly increased 
(P < 0.05) in IR rats (69.6 ± 9.1ng/ml) compared to 
control rats (33.8 ± 4.6ng/ml). Serum oestradiol levels 
were however not significantly different in IR rats (16.9 
+ 1.54ng/ml) compared to control rats (17.5 + 
1.87ng/ml) as shown in Figure 6. Picture of Day 19 
foetuses and placentae from insulin resistant and control 
pregnant rats is presented as Figure 7 at X40 
magnification. 
 
1: Effect of insulin resistance (IR) on placental and 
foetal parameters in rats 
 
Placental weight, placental diameter and placental central 
thickness were significantly increased (*P < 0.05) in IR rats 
compared to control rats. Foetal weight and placental to foetal 
weight ratio were significantly reduced (*P < 0.05) in IR rats 
compared to controls. 
 
Table 2: Effect of insulin resistance (IR) on placental 
morphology in rats 
 
The junctional zone of the placenta, number of glycogen and 
trophoblast giant cells were increased (*P < 0.05) in IR 
compared to control rat placentae (HPF: High Power Field) 
 
Effect of insulin resistance (IR) on maternal serum and 
amniotic fluid QUICKI values in pregnant rats 
QUICKI of maternal serum and amniotic fluid of IR and 
control rats, derived from maternal and amniotic fluid 
insulin (Io) and glucose (Go) levels as the inverse log 
    Placental progesterone receptor in insulin-resistant pregnant rats 
 
 
103           J. Afr. Ass. Physiol. Sci. 7 (2): 2019        Ogunsola et al. 
 
 
sum of insulin in micro - unit per millilitre and glucose 
in milligram per decilitre, are shown in Figure 5. 
QUICKI of pregnant IR rats were significantly (P < 
0.05) lower (0.116+0.002, 0.057+0.002) compared to 
control rats (0.223+0.001, 0.090+0.002) respectively. 
 
 
Fig. 9: Photomicrographs of day 19 rat placentae showing 
immunohistological localization of progesterone receptors 
(PR- arrows) in control and IR rat placentae. The number of 
PR per HPF is reduced in IR compared to control rat placantae. 
Magnification 40x 
 
Effect of insulin resistance (IR) on serum progesterone 
and oestradiol levels in pregnant rats 
Serum progesterone levels were significantly increased 
(P < 0.05) in IR rats (69.6 ± 9.1ng/ml) compared to 
control rats (33.8 ± 4.6ng/ml). Serum oestradiol levels 
were however not significantly different in IR rats (16.9 
+ 1.54ng/ml) compared to control rats (17.5 + 
1.87ng/ml) as shown in Figure 6.  Picture of Day 19 
foetuses and placentae from insulin resistant and control 





Fig. 10: Photomicrograph of day 19 rat placenta showing 
immunohistological localization of oestrogen receptors (ER- 
Asterisks) in control and insulin resistant (IR) rat placentae. 
100x. Scale bar -10μm.  
 
 
Fig. 11: Progesterone receptor (PR) and oestrogens receptor 
(ER) counts in control and insulin resistant (IR) rat placentae. 
PR counts are reduced (*P < 0.05) in IR placentae compared 
to controls. No significant difference was observed in ER 
counts of IR and control placentae. 
 
 
Effect of insulin resistance (IR) on placental glycogen-
containing cells in rats 
The numbers of glycogen-containing cells (GC) in the 
placentae of IR and control rats are shown in Table 2 and 
Figure 8. The number of GC per high power field (HPF) 
in the placentae of IR rats (146.5±7.0 counts/HPF) were 
significantly increased (P < 0.05) compared to control 
rats (82.5±6.5 counts/HPF). 
 
Effect of insulin resistance (IR) on trophoblast giant 
cells (TGC) in rat placentae  
The numbers of trophoblast giant cells (TGC) in the 
placentae of IR and control rats are shown in Table 2 and 
Figure 8. The number of TGC per high power field 
(HPF) in the placentae of IR rats (41.4+11.2 
counts/HPF) were significantly increased (P < 0.05) 
compared to control rats (32.6+5.9 counts/HPF). 
 
Effect of maternal diabetes on placental junctional zone 
in rats  
The size of junctional zones of IR and control rat 
placentae is shown in Table 2 and Figure 8. The 
junctional zones of IR rats (214.8±43.1µm) were 
significantly enlarged (P < 0.05) compared to control 
rats (124.6±28.7µm). 
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Effect of insulin resistance on progesterone (PR) and 
oestrogen (ER) receptors expression in pregnant rat 
placentae 
The immunohistological expression of progesterone 
receptors in control and IR pregnant rat placentae are 
shown in Figure 9 while that of oestrogen receptors in 
control and IR pregnant rat placentae are shown in 
Figure 10. PR and ER counts per high power field (HPF) 
in control and IR pregnant rat placentae are shown in 
Figure 11. PR counts per HPF were significantly reduced 
(P < 0.05) in IR (117.0±12.5) compared to control rats 
(139.5±22.5) while there was no significant difference in 
ER counts between the two groups.  
 
DISCUSSION 
Foetal exposure to a diabetic intra-uterine environment 
is known to influence the aetiology of metabolic 
disorders in the offspring later in life, a phenomenon 
known as foetal programming. However, the underlying 
mechanisms and the role of pregnancy hormones and the 
placenta in foetal programming are incompletely 
understood. The present study therefore used nutritional 
exposure to high fructose diet to develop an insulin 
resistance model (Suga et al., 2000; Basciano et al., 
2005; Arikawe et al., 2008; Iranloye et al., 2011). This 
model was used to investigate the effect of insulin 
resistance on maternal serum progesterone and 
oestrogens levels, placental morphology, placental 
expression of progesterone and oestrogen receptors in 
rats. 
Fructose feeding has been used to induce type 2 
diabetes mellitus in animal models (Suga et al., 2000; 
Basciano et al., 2005; Arikawe et al., 2008; Iranloye et 
al., 2011). In the present study, successful induction of 
insulin resistance was evidenced by hyperglycaemia and 
hyperinsulinemia after 12 weeks of chronic fructose 
feeding. Fasting blood glucose levels increased 
progressively in the insulin resistance group from the 5th 
week and diabetic levels (>120mg/dl) were reached at 
the 12th week. During pregnancy, maternal fasting blood 
glucose (FBG) level was higher in the insulin resistance 
group, while the control rats had values below 90mg/dl. 
Maternal serum insulin and C-peptide levels were over 
two - folds the control, while the quantitative insulin 
sensitivity check index (QUICKI) of IR rats were 
reduced in this study. This is an indication of a reduction 
in insulin sensitivity in the insulin resistant pregnant rats.  
Amniotic fluid glucose level of IR rats was 
significantly increased (P < 0.05) in this study, this 
suggest an increased influx of glucose from maternal 
circulation to foetal circulation through the placenta. The 
transport of glucose through the placental is essential for 
foetal growth and development, as it serves as the sole 
foetal energy source (Magnusson-Olsson et al., 2006). 
Movement of glucose across the placenta is rapid due to 
the high capacity of the placenta to transport nutrients, 
with saturation only being reached at a very high 
glycaemic maternal blood concentration above 
350mg/dl (Desoye and Myatt, 2004).  
The present study also showed that amniotic fluid 
insulin was increased in the insulin resistant rats. 
Maternal insulin however cannot cross the placental 
barrier due to its high molecular weight (Dickinson et 
al., 1990; Barbour et al., 2007) implying that amniotic 
fluid insulin is of foetal origin (foetal pancreatic beta 
cells). This finding suggests that maternal 
hyperglycaemia, leading to an increased influx of 
glucose to foetal circulation through the placenta, results 
in a compensatory increase in foetal insulin production, 
as shown by the increase in amniotic fluid insulin levels 
observed in the IR rats. A similar result was reported by 
Saito et al., (2010) in streptozotocin-induced diabetic 
rats.  
 Foetal pancreas produces insulin to regulate the 
increased influx of glucose from the maternal 
circulation, since maternal insulin cannot cross the 
placenta barrier (Habibulla et al., 2006). Insulin acts by 
increasing glucose uptake by foetal cells, thus promoting 
foetal growth (Fowden and Forhead, 2004). The elevated 
amniotic fluid insulin levels observed in the IR rats is 
suggestive of foetal hyperinsulinaemia. Foetal insulin is 
excreted through foetal urine into amniotic fluid, and has 
been reported to increase as foetal insulin production 
increases (Illsley, 2000). Increased amniotic fluid insulin 
has also been associated with increased foetal growth 
(Tisi et al., 2011; Jansson et al., 2006), macrosomia 
(Jansen et al., 2003) and foetal morbidity (Buchanan et 
al., 1995) in previous studies.  
 Placental hormones are essential for pregnancy 
maintenance, they function by exerting autocrine and 
paracrine effects that regulate decidualization, placental 
development, angiogenesis, endometrial receptivity, 
embryo implantation, immunotolerance and foetal 
development (Costa, 2015). In addition, because 
placental hormones are released into maternal 
circulation, the profile of their blood levels during 
pregnancy has been the target of intense research 
towards finding potential reliable biomarkers to predict 
and diagnose pregnancy associated complications.  
  In the present study, maternal serum progesterone 
levels were increased in the IR rats, suggesting that 
progesterone may play a role in increasing insulin 
resistance state of diabetic pregnancies. However, no 
significant increase was observed in oestradiol levels of 
IR rats. This hormonal imbalance may impair foetal 
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2012. Progesterone, a steroid hormone crucial for the 
maintenance of pregnancy, has been reported to be 
involved in maternal metabolic changes during 
pregnancy, promoting hyperphagia, fat storage and 
insulin resistance (Butte, 2000).  
The effect of progesterone is mediated by its 
receptors - progesterone receptors (PR), which has been 
identified in the placenta aside the uterus, suggesting that 
the placenta itself is a target for progesterone action 
(Tsai and O'Malley, 1994; Shanker and Rao, 1999). 
Little is currently known about the expression of PR in 
the placenta of gestational diabetic and type 2 diabetic 
pregnancies. However, previous studies have reported 
that progesterone influences pancreatic beta cell 
function and contributes to insulin resistance state in 
pregnancy (Polderman et al., 1994; Freeman, 2010). 
In the present study, progesterone receptor 
expression was down regulated in the placenta of IR rats, 
this may be due to the increase in maternal serum 
progesterone levels observed in this study. Previous 
studies have linked changes in the expression of 
placental receptors to impaired foetal development 
(Norberg et al., 1998; Jansson et al., 2002). During 
gestation, the placenta produces progesterone which 
through its interaction with progesterone receptors 
exerts its many effects. Specific intracellular 
progesterone receptors (PR) have been reported to 
mediate the genomic signalling of progesterone.  
Oestrogens have also been reported to be involved 
in the development of maternal insulin resistance during 
pregnancy (Gonzalez et al., 2000; Gonzalez et al., 2002; 
Barros et al., 2009). In this study, however, no 
significant difference was observed in maternal serum 
oestradiol levels and placental expression of oestrogen 
receptors in IR rats. This finding suggests that placental 
oestrogen receptors is not impaired in this model of 
diabetic pregnancy. 
Placental weight, placental central thickness and 
placental diameter of IR rats were increased in this 
study. This finding was paralleled by an increase in the 
number of placental glycogen-containing cells, 
trophoblast giant cells and size of the junctional zones in 
the diabetic placentae. These findings are suggestive of 
placental hypertrophy, which may represent its adaptive 
response to the hyperglycaemic maternal environment, 
as evidenced by the increased number of glycogen-
containing cells in the IR placentae. The increase in 
placental diameter represents an increased area of 
uterine attachment and placental exchange area. Increase 
in placental central thickness has been reported to 
represent an increase in trophoblast angiogenesis and 
density of blood vessels (Elshennawy, 2016). 
These structural adaptive response of the placenta to 
maternal insulin resistance were explained by previous 
studies to be a compensatory mechanism caused by 
changes in glucose metabolism and hormone production 
by the placenta (Vitoratos et al., 2010; Martino et al., 
2016). A similar observation was reported by Evers et 
al., 2003, in the placenta of Type 1 diabetic women, and 
in the placenta of gestational diabetic mothers (Sharmila 
et al., 2017). Pathak et al., 2010’s report was however 
contrary to this finding, they observed no correlation 
between streptozotocin (STZ)- induced maternal 
diabetes and changes in placental morphology in rats. 
This difference in finding may be due to the model of 
maternal diabetes used for the study, as STZ induces 
type 1 diabetes mellitus, via cytotoxic destruction of 
pancreatic beta cells. The present study however induced 
insulin resistant state in rats with intact pancreatic beta 
cells.  
 
  Placental to foetal weight ratio was significantly 
reduced in the IR rats compared to Control rats. This 
may be due to consequential increase in placental 
parameters/morphology in the IR rats compared to the 
Control rats as presented in tables 1 and 2. Yessofou and 
Moutairou (2011) also reported a similar finding in their 
study. Placental to foetal weight ratio are predictors of 
long-term adverse outcome for the offspring as reported 
by Godfrey in 2002. Decrease in placental to foetal 
weight ratio may represent an adaptive response by the 
foeto- placental unit to an unfavourable maternal 
environment. Findings from this study therefore 
suggests that progesterone and the placenta play roles in 




The study shows that maternal insulin resistance 
increases progesterone production, leading to a down 
regulation of progesterone receptor expression in the 
placenta. The placenta also adapts structurally to 
maternal insulin resistance, a form of type 2 diabetes 
mellitus, by increases in weight, central thickness, 
diameter and trophoblast giant cells.  
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